Power Law company profile

Tactile Systems Technology

Biotech & Life Sciences · Minneapolis, United States · Founded 1995 · IPO 2016 Thoroughbred

Lymphedema and Venous Ulcer Treatment; Therapy, Pumps At Home

Valuation

$441M

Market cap · May/2026

Revenue

$330M

Latest reported FY

EBITDA

$49M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Tactile Systems Technology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Galen Partners

Series B+ 1 investor entered at this stage

Radius Ventures

Global footprint

Where Tactile Systems Technology has talent and traffic

Workforce by country

🇺🇸 United States · Minneapolis HQ

Book a demo for the full country breakdown

Web traffic by country

110K monthly visits
across markets

🇺🇸 United States64.8%

🇨🇦 Canada12.2%

🇬🇧 United Kingdom6%

🇦🇺 Australia5.5%

🇮🇳 India3.1%

Top 5 markets shown

Market sentiment

What the market is saying about Tactile Systems Technology

An AI-synthesized read of the highest-engagement posts about Tactile Systems Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tactile Systems Technology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles